<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000689.v1.p1" parentStudy="phs000689.v1.p1" createDate="2013-12-12" modDate="2014-01-23">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Adolfo Ferrando</td><td>Institute for Cancer Genetics, Columbia University, New York, NY, USA</td></tr>
		<tr><td>Funding Source</td><td>Translational Research Grant</td><td>Leukemia and Lymphoma Society</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Genomic Analysis of Peripheral T-Cell Lymphomas</StudyNameEntrez>
	<StudyNameReportPage>Genomic Analysis of Peripheral T-Cell Lymphomas</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case-Control</StudyType>
		<StudyType>Tumor vs. Matched-Normal</StudyType>
		<StudyType>Exome Sequencing</StudyType>
		<StudyType>RNA Sequencing</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>Peripheral T-cell lymphomas (PTCLs) are a heterogeneous and poorly understood group of non Hodgkin lymphomas. We aim to identify new genetic alterations in PTCL transformation by using a combination of whole exome sequencing of tumor-normal DNA pairs, RNAseq analysis and targeted deep sequencing of candidate genes. Our data identified highly recurrent mutations in epigenetic factors such as TET2, DNMT3A and IDH2 as well as a new highly prevalent mutation in RHOA, the G17V allele that is present in almost 70% of angioimmunoblastic T-cell lymphomas (AITL) and almost 20% of not otherwise specified PTCL (PTCL NOS) samples. In addition, we describe new and recurrent genetic defects including mutations in FYN, ATM, B2M and CD58 implicating SRC signaling, impaired DNA damage response and escape from immune surveillance processes as key players in the pathogenesis of PTCL.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p> <ol> <li>De novo diagnoses of peripheral T-cell lymphoma</li> <li>Matched tumor and normal genomic DNA (for exome sequencing only)</li> </ol> </p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="24413734"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Lymphoma, T-Cell, Peripheral"/>
		<Disease vocab_source="MESH" vocab_term="Lymphoma, Non-Hodgkin"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Adolfo Ferrando</AttName>
			<Institution>Institute for Cancer Genetics, Columbia University, New York, NY, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>Translational Research Grant</AttName>
			<Institution>Leukemia and Lymphoma Society</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyURLs>
		<Url name="Institute for Cancer Genetics" url="http://icg.cumc.columbia.edu"/>
	</StudyURLs>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="DS-CA-PUB-MDS" longName="Disease-Specific (Cancer, PUB, MDS)"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NCI</DacName>
      <DacFullName>NCI</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000689.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000689.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000689.v1.p1" FileName="eNCI_0180_DUC_11.25.2013.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Disease-Specific (Cancer, PUB, MDS)</ConsentName>
        <ConsentAbbrev>DS-CA-PUB-MDS</ConsentAbbrev>
        <UseLimitation>Use of the data must be related to Cancer.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Use of the data includes methods development research (e.g., development of software or algorithms).</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
